Mitochondrial DNA mutations in blood samples from HIV-1-infected children undergoing long-term antiretroviral therapy

Yabo Ouyang1,2, Luxin Qiao1,2, Kai Liu1,2, Yunjin Zang1, Yu Sun1, Yaowu Dong3, Daojie Liu1,2, Xianghua Guo1,2, Feili Wei1,2, Minghua Lin1,2, Fujie Zhang4, Dexi Chen1,2
1Beijing You An Hospital, Capital Medical University, Beijing, China
2Beijing Institute of Hepatology, Beijing, China
3Branch of Shang Cai, Henan province, Division of Treatment and Care, National Center for AIDS/STD Control and Prevention, China
4Division of Treatment and Care, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, China

Tài liệu tham khảo

Sanchez, 2003, Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children, Pediatr. Infect. Dis. J., 22, 863, 10.1097/01.inf.0000091282.70253.5f

Park, 2011, Mitochondrial DNA mutations in disease and aging, J. Cell Biol., 193, 809, 10.1083/jcb.201010024

Lewis, 2003, Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective, Nat. Rev. Drug Discov., 2, 812, 10.1038/nrd1201

Cote, 2002, Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients, N. Engl. J. Med., 346, 811, 10.1056/NEJMoa012035

Hoy, 2004, Changes in mitochondrial DNA in peripheral blood mononuclear cells from HIV-infected patients with lipoatrophy randomized to receive abacavir, J. Infect. Dis., 190, 688, 10.1086/422602

Maagaard, 2006, Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients, Antiviral Ther., 11, 601, 10.1177/135965350601100505

Martin, 2003, Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitors, Am. J. Hum. Genet., 72, 549, 10.1086/367849

Liu, 2013, Mitochondrial toxicity studied with the PBMC of children from the Chinese national pediatric highly active antiretroviral therapy cohort, PLoS One, 8, e57223, 10.1371/journal.pone.0057223

Foster, 2008, HIV and mitochondrial toxicity in children, J. Antimicrob. Chemother., 61, 8, 10.1093/jac/dkm411

McComsey, 2004, Metabolic complications of HIV therapy in children, AIDS, 18, 1753, 10.1097/00002030-200409030-00004

Jao, 2014, Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants, Pediatr. Infect. Dis. J., 33, 734, 10.1097/INF.0000000000000224

Ortiz, 2011, No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy, J. Infect. Dis., 203, 620, 10.1093/infdis/jiq106

Finsterer, 2000, Complex mitochondriopathy associated with 4 mtDNA transitions, Eur. Neurol., 44, 37, 10.1159/000008190

Rollins, 2009, Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder, PLoS One, 4, e4913, 10.1371/journal.pone.0004913

McComsey, 2005, Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine, AIDS, 19, 15, 10.1097/00002030-200501030-00002

Cote, 2003, Mitochondrial:nuclear DNA ratios in peripheral blood cells from human immunodeficiency virus (HIV)-infected patients who received selected HIV antiretroviral drug regimens, J. Infect. Dis., 187, 1972, 10.1086/375353

Saitoh, 2007, Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy, Antimicrob. Agents Chemother., 51, 4236, 10.1128/AAC.00893-07